Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Kentucky Business Review.
Press releases published on September 16, 2025

Flux Power Reports Fourth Quarter and Fiscal Year 2025 Financial Results
Q4 Revenue increased 25% to $16.7 million over Prior Year Period; Fiscal Year 2025 Revenue Up 9% over 2024 VISTA, Calif., Sept. 16, 2025 (GLOBE NEWSWIRE) -- Flux Power Holdings, Inc. (NASDAQ: FLUX), a leading developer of advanced lithium-ion energy …

Resmed Announces Participation in the Bank of America Global Healthcare Conference 2025
SAN DIEGO, Sept. 16, 2025 (GLOBE NEWSWIRE) -- Resmed (NYSE: RMD, ASX: RMD) today announced Mick Farrell, chairman and chief executive officer, and Dr. Carlos Nunez, chief medical officer, will present at the Bank of America Global Healthcare Conference …

Safe Bulkers, Inc. Announces Results of 2025 Annual Meeting of Stockholders
MONACO, Sept. 16, 2025 (GLOBE NEWSWIRE) -- Safe Bulkers, Inc. (the “Company”) (NYSE: SB), an international provider of marine drybulk transportation services, announced the election of three Class II directors at the Company’s annual meeting of …

Reed’s Announces Closing of $5.0 Million Private Placement and Board Updates
NORWALK, Conn., Sept. 16, 2025 (GLOBE NEWSWIRE) -- Reed’s, Inc. (OTCQX: REED) (“Reed’s” or the “Company”), owner of the nation’s leading portfolio of handcrafted, natural ginger beverages, today announced the closing of a securities purchase agreement for …

Cytokinetics Announces Proposed Private Placement of $550.0 Million of Convertible Senior Notes
SOUTH SAN FRANCISCO, Calif., Sept. 16, 2025 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (“Cytokinetics”) (Nasdaq: CYTK) today announced its intention to offer, subject to market conditions and other factors, $550.0 million aggregate principal amount of …

Kura Oncology Highlights Preclinical Data Demonstrating Potential of Farnesyl Transferase Inhibitors to Overcome Drug Resistance in Combination with Key Targeted Therapies Across Multiple Tumor Types
Analyst/Investor event showcases opportunities for KO-2806 (darlifarnib) in combination with PI3Kα inhibitors, KRAS inhibitors and antiangiogenic tyrosine kinase inhibitors (TKIs) Preliminary clinical data and KO-2806 development plans to be presented in …

FormFactor Announces Participation in 17th Annual CEO Investor Summit 2025
LIVERMORE, Calif., Sept. 16, 2025 (GLOBE NEWSWIRE) -- FormFactor, Inc. (NASDAQ: FORM), today announced management’s participation in the 17th Annual CEO Investor Summit 2025, being held Tuesday, October 7th at the Arrogant Butcher restaurant in Phoenix, …


Kaixin Holdings Announces Annual General Meeting Results
BEIJING, Sept. 16, 2025 (GLOBE NEWSWIRE) -- Kaixin Holdings (“Kaixin” or the “Company”) (NASDAQ: KXIN) today announced that all resolutions presented to the shareholders at its annual general meeting held on September 13, 2025 (the “Annual General Meeting …

TSWHZC Reaffirms Commitment to Transparency with User Protection Initiative in Response to Online Misinformation
Los Angeles, CA, Sept. 16, 2025 (GLOBE NEWSWIRE) -- Tswhzc CRYPTO GROUP LTD, operating as TSWHZC, a next-generation crypto asset exchange, today announced a major User Protection and Transparency Initiative. This proactive measure is designed to reinforce …

LUMINAR DEADLINE: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Luminar Technologies, Inc. Investors to Secure Counsel Before Important September 22 Deadline in Securities Class Action - LAZR
NEW YORK, Sept. 16, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Luminar Technologies, Inc. (NASDAQ: LAZR) between March 20, 2025 and May 14, 2025, both dates inclusive (the “Class …

With $3M Raised, Ozak AI Presale Gains Attention as 2025’s Top 100x Altcoin Project
ROAD TOWN, British Virgin Islands, Sept. 16, 2025 (GLOBE NEWSWIRE) -- Ozak AI (OZ) has firmly positioned itself as one of the most exciting crypto presales of 2025, already raising more than $3 million in funding. With tokens priced at just $0.01 in Stage …


Microbot Medical Announces First Closing of Exercise of Outstanding Preferred Investment Options of Up to $92.2 Million in Gross Proceeds
HINGHAM, Mass., Sept. 16, 2025 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT) (“Microbot” or the “Company”), today announced the first closing of its previously announced exercise of certain outstanding preferred investment options to purchase up …

Baringa Survey Finds that Legacy Tech Infrastructure Remains a Challenge for Banks as Demand for Digital Banking Grows
NEW YORK, Sept. 16, 2025 (GLOBE NEWSWIRE) -- Legacy technology systems and infrastructure may be keeping banks from meeting growing customer demand for digital banking, according to new research from Baringa, a leading global management consultancy. …

Electra Provides Update on Restructuring Terms to Advance Completion of Cobalt Refinery
TORONTO, Sept. 16, 2025 (GLOBE NEWSWIRE) -- Electra Battery Materials Corporation (NASDAQ: ELBM; TSX-V: ELBM) (“Electra” or the “Company”) announces amendments to its previously disclosed recapitalization and restructuring initiative (the “Restructuring”), …

ROSEN, NATIONALLY REGARDED INVESTOR COUNSEL, Encourages Dow Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – DOW
NEW YORK, Sept. 16, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Dow Inc. (NYSE: DOW) between January 30, 2025 and July 23, 2025, both dates inclusive (the “Class Period”), of the …

ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Lineage, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – LINE
NEW YORK, Sept. 16, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of Lineage, Inc. (NASDAQ: LINE) common stock pursuant and/or traceable to the registration statement issued in connection with Lineage’s …
![[Latest] Global Isoparaffin Solvents Market Size/Share Worth USD 1,325.48 Million by 2034 at a 4.27% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)](/images/pressrelease-small.png)
[Latest] Global Isoparaffin Solvents Market Size/Share Worth USD 1,325.48 Million by 2034 at a 4.27% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)
Austin, TX, USA, Sept. 17, 2025 (GLOBE NEWSWIRE) -- Custom Market Insights has published a new research report titled “Isoparaffin Solvents Market Size, Trends and Insights By Type (Type, C4-C8, C9-C11, C12, C13-C14, C15<), By Application (Metal Working, …